Actinium Pharmaceuticals, Inc.ATNMNYSE
Loading
Year-over-year debt growth rate
Latest
-11.40%
↓ 135% vs avg
Percentile
P31
Within normal range
Streak
7 qtr
Consecutive declineDecelerating
Average
32.46%
Historical baseline
| Period | Value |
|---|---|
| Q3 2025 | -11.40% |
| Q2 2025 | -9.98% |
| Q1 2025 | -8.90% |
| Q4 2024 | -8.07% |
| Q3 2024 | -7.46% |
| Q2 2024 | -6.71% |
| Q1 2024 | -6.20% |
| Q4 2023 | -4.43% |
| Q3 2023 | -5.39% |
| Q2 2023 | -5.00% |
| Q1 2023 | -4.69% |
| Q4 2022 | -0.77% |
| Q3 2022 | -1.77% |
| Q2 2022 | 1244.16% |
| Q1 2022 | -36.45% |
| Q4 2021 | -26.37% |
| Q3 2021 | -20.42% |
| Q2 2021 | -16.56% |
| Q1 2021 | -14.09% |
| Q4 2020 | -15.85% |
| Q3 2020 | -19.69% |
| Q2 2020 | -16.19% |
| Q1 2020 | -8.75% |
| Q4 2019 | 14.12% |
| Q3 2019 | -11.75% |
| Q2 2019 | -9.95% |
| Q1 2019 | 499.58% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q4 2016 | 0.00% |
| Q3 2016 | -100.00% |
| Q2 2016 | -49.71% |
| Q1 2016 | -32.96% |
| Q4 2015 | 0.00% |